Foundation Medicine (FMI), Takeda Announce Collaboration To Develop FoundationOne CDx and FoundationOne Liquid CDx as Companion Diagnostics for Takeda's Late-Stage Lung Cancer Portfolio Sep 18, 2020 07:00AM
Foundation Medicine Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy Aug 6, 2018 12:00PM
Roche Purchases Shares in Tender Offer for FMI Jul 31, 2018 01:00AM
Foundation Medicine (FMI), Guardant Health Agree to Settle Patent Infringement Lawsuit Jul 18, 2018 04:00PM
Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit Jul 18, 2018 04:00PM
View Older Stories

Jul 2, 2018 11:35AM Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash
Jun 19, 2018 06:18AM Roche to Acquire Foundation Medicine (FMI) for $137/Share, or $5.3B
Jun 19, 2018 01:00AM Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology
Jun 5, 2018 07:00AM Foundation Medicine to Present at Upcoming Investor Conferences
May 29, 2018 07:00AM Foundation Medicine and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling (CGP) to Inform Personalized Approaches in Cancer Care
May 24, 2018 07:05AM Foundation Medicine (FMI) Reports Immuno-Oncology Companion Diagnostics Collaboration with Merck (MRK)
May 24, 2018 07:00AM Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck
May 21, 2018 07:03AM Foundation Medicine (FMI) Secures New ADLT Status for FoundationOne CDx
May 21, 2018 07:00AM Foundation Medicine Receives New ADLT Status for FoundationOne CDx™ from the Centers for Medicare and Medicaid Services (CMS)
May 2, 2018 04:01PM Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights
May 2, 2018 07:00AM Foundation Medicine Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer
Apr 26, 2018 06:00PM Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China
Apr 26, 2018 07:25AM Foundation Medicine (FMI) Says New Liquid Biopsy Assay Granted Breakthrough Device Designation
Apr 26, 2018 07:00AM Foundation Medicine’s New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration
Apr 17, 2018 07:00AM Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call
Apr 11, 2018 07:03AM Foundation Medicine (FMI), Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling
Apr 11, 2018 07:00AM Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies
Apr 9, 2018 08:54AM Cancer Treatment Centers of America and Foundation Medicine Launch Joint Educational Campaign to Raise Consumer Awareness of Precision Medicine Approaches in Cancer Care
Mar 30, 2018 07:00AM Foundation Medicine Announces Commercial Availability of FoundationOne CDx™, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagno
Mar 18, 2018 10:19PM Foundation Medicine Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDx™ Across All Solid Tumo
Mar 16, 2018 02:00AM Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx™ in Japan
Mar 13, 2018 04:05PM Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit
Mar 8, 2018 06:30AM Foundation Medicine to Present at Cowen and Company’s 38th Annual Healthcare Conference
Mar 7, 2018 04:01PM Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook
Feb 13, 2018 06:30AM Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2017 Financial Results and Conference Call
Feb 5, 2018 07:09AM Bristol-Myers Squibb (BMY) Reports Pivotal Phase 3 CheckMate-227 Study Provides Superior Progression-Free Survival (PFS) with the Opdivo Plus Yervoy Combination
Feb 5, 2018 06:59AM Pivotal Phase 3 CheckMate -227 Study Demonstrates Superior Progression-Free Survival (PFS) with the Opdivo Plus Yervoy Combination Versus Chemotherapy in First-Line Non-Small Cell Lung Cancer (NSCLC)
Jan 30, 2018 07:00AM Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clin
Jan 16, 2018 07:05AM Foundation Medicine (FMI), Pfizer (PFE) Announce Pact to Develop Companion Diagnostics for Pfizer's Oncology Portfolio
Jan 16, 2018 07:00AM Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer’s Oncology Portfolio
Jan 8, 2018 06:34AM Foundation Medicine (FMI) Prelim. Q4 Revenue Tops Views
Jan 8, 2018 06:30AM Foundation Medicine Reports Preliminary 2017 Results
Jan 3, 2018 04:01PM Foundation Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 6, 2017 07:00AM Foundation Medicine and Collaborators to Present New Data at the American Society of Hematology (ASH) Annual Meeting that Supports Use of FoundationOne®Heme to Advance Personalized Medicine in Blood
Nov 30, 2017 11:15PM FDA Approves Foundation Medicine’s FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics
Nov 1, 2017 04:01PM Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights
Oct 16, 2017 07:00AM Foundation Medicine to Present Validation for FoundationOne CDx™, a Comprehensive Genomic Profiling Assay for Advancing Precision Cancer Care
Oct 12, 2017 06:30AM Foundation Medicine Announces Timing for Third Quarter 2017 Financial Results and Conference Call
Oct 10, 2017 05:00PM Foundation Medicine Appoints Tom Civik as Chief Commercial Officer
Oct 2, 2017 07:00AM Foundation Medicine Receives Approval from the State of New York for its FoundationACT Liquid Biopsy Assay
Sep 8, 2017 07:00AM Foundation Medicine to Present Validation Data for Its Assay Measuring Tumor Mutational Burden in Blood (bTMB), a New, Non-Invasive Predictor of Response to Immunotherapy
Aug 30, 2017 06:30AM Foundation Medicine to Present at the 2017 Wells Fargo Healthcare Conference
Aug 15, 2017 08:00AM Cancer Treatment Centers of America® and Foundation Medicine® Join Forces to Advance Precision Cancer Treatment
Aug 1, 2017 04:01PM Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights
Jul 12, 2017 06:30AM Foundation Medicine Announces Timing for Second Quarter 2017 Financial Results and Conference Call
Jun 8, 2017 07:00AM ASCO and Foundation Medicine Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization (TAPUR) Study
Jun 7, 2017 06:30AM Foundation Medicine to Identify Patients Eligible for National Cancer Institute’s NCI-MATCH (Molecular Analysis for Therapy Choice) Study
Jun 5, 2017 06:30AM Foundation Medicine to Present at Upcoming Investor Conferences
May 18, 2017 07:13AM Foundation Medicine (FMI) And Its Collaborators to Present New Data at ASCO
May 18, 2017 07:00AM Foundation Medicine and Its Collaborators to Present New Data at ASCO 2017 Supporting the Integration of Comprehensive Genomic Profiling (CGP) in Personalized Clinical Care in Oncology
View Older Stories